Jeisys Medical Inc. (KOSDAQ: 287410)
South Korea
· Delayed Price · Currency is KRW 12,880
+10 (0.08%)
Oct 11, 2024, 9:00 AM KST
Jeisys Medical Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | 27,969 | 24,800 | 27,130 | 13,592 | 7,543 |
| Depreciation & Amortization | 4,531 | 4,263 | 3,041 | 2,474 | 2,329 |
| Loss (Gain) From Sale of Assets | 32.37 | 24.71 | 63.69 | 17.85 | 331.99 |
| Loss (Gain) From Sale of Investments | 82.46 | 83.03 | -295.44 | -239.53 | -10.02 |
| Stock-Based Compensation | 1,325 | 1,582 | 2,026 | 1,632 | 265.21 |
| Provision & Write-off of Bad Debts | 248.77 | 12.71 | -14.43 | -56.24 | 706.35 |
| Other Operating Activities | 6,916 | 4,284 | 6,527 | 8,359 | 3,817 |
| Change in Accounts Receivable | -6,996 | -6,390 | -4,024 | -3,523 | 638.86 |
| Change in Inventory | -6,202 | -2,707 | -10,013 | -5,590 | 703.38 |
| Change in Accounts Payable | 4,065 | 1,212 | -43.78 | 1,092 | 169.01 |
| Change in Other Net Operating Assets | -1,737 | 5,512 | 854.62 | 2,543 | -370.11 |
| Operating Cash Flow | 30,236 | 32,678 | 25,251 | 20,301 | 16,123 |
| Operating Cash Flow Growth | -14.99% | 29.41% | 24.38% | 25.91% | - |
| Capital Expenditures | -19,357 | -14,291 | -12,428 | -2,391 | -2,450 |
| Sale of Property, Plant & Equipment | 24.71 | 20.35 | 35.88 | 3.1 | 27.3 |
| Cash Acquisitions | - | - | - | 962.47 | - |
| Sale (Purchase) of Intangibles | -781.66 | -726.75 | -1,084 | -393.01 | -527 |
| Investment in Securities | -50,037 | -1,934 | -7,525 | 7,599 | -421.1 |
| Other Investing Activities | -905.54 | -728.25 | -97.74 | -100.45 | -25.9 |
| Investing Cash Flow | -71,057 | -17,660 | -21,099 | 5,681 | -3,397 |
| Short-Term Debt Issued | - | 1,276 | 119.5 | 3,257 | - |
| Long-Term Debt Issued | - | 11,605 | 9,770 | - | 1,405 |
| Total Debt Issued | 58,672 | 12,881 | 9,890 | 3,257 | 1,405 |
| Short-Term Debt Repaid | - | -3,257 | -85.98 | -3,257 | -450 |
| Long-Term Debt Repaid | - | -2,115 | -7,468 | -1,501 | -1,674 |
| Total Debt Repaid | -5,411 | -5,372 | -7,554 | -4,758 | -2,124 |
| Net Debt Issued (Repaid) | 53,262 | 7,509 | 2,336 | -1,501 | -718.97 |
| Issuance of Common Stock | 792.31 | 7,776 | - | - | - |
| Repurchase of Common Stock | -5,532 | -10,001 | - | -263.7 | - |
| Other Financing Activities | -7,557 | -10,376 | -318.08 | -7,544 | 34 |
| Financing Cash Flow | 40,965 | -5,092 | 2,018 | -9,309 | -684.97 |
| Foreign Exchange Rate Adjustments | 199.86 | -678.4 | -877.86 | 27.85 | -533.76 |
| Miscellaneous Cash Flow Adjustments | -0 | -0 | 0 | - | - |
| Net Cash Flow | 343.45 | 9,247 | 5,292 | 16,700 | 11,508 |
| Free Cash Flow | 10,879 | 18,387 | 12,823 | 17,910 | 13,673 |
| Free Cash Flow Growth | -57.45% | 43.40% | -28.41% | 30.99% | - |
| Free Cash Flow Margin | 6.48% | 12.86% | 11.00% | 22.03% | 28.59% |
| Free Cash Flow Per Share | 140.86 | 237.58 | 167.23 | 232.60 | 250.32 |
| Cash Interest Paid | 248.78 | 132.88 | 299.16 | 343.21 | 370.72 |
| Cash Income Tax Paid | 3,213 | 7,128 | 1,229 | 1,357 | 473.42 |
| Levered Free Cash Flow | -1,989 | 5,153 | 5,720 | 11,537 | - |
| Unlevered Free Cash Flow | -1,776 | 5,292 | 5,965 | 11,779 | - |
| Change in Net Working Capital | 11,345 | 8,232 | 6,787 | 4,296 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.